COSM
Cosmos Health Inc.
+0.03 (+9.27%)0.30USD1.5M成交股數30.1M市值–本益比(近四季)0.4股價營收比+28.8%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 19.0M+29% | 17.9M+31% | 19.7M+59% | 17.1M+30% | 14.7M+1% | 13.7M-13% | 12.4M-3% | 13.2M+7% | 14.6M | 15.8M | 12.8M | 12.4M |
| 營業成本 | 17.5M | 16.5M | 17.6M | 14.5M | 13.6M | 11.7M | 11.2M | 12.4M | 13.3M | 14.6M | 11.6M | 11.4M |
| 毛利 | 1.5M+30% | 1.4M-33% | 2.1M+72% | 2.6M+239% | 1.2M-13% | 2.0M+67% | 1.2M-1% | 767K-19% | 1.3M | 1.2M | 1.2M | 947K |
| 毛利率 | 8.0% | 7.7% | 10.6% | 15.2% | 7.9% | 14.9% | 9.7% | 5.8% | 9.1% | 7.8% | 9.5% | 7.7% |
| 研發費用 | 69K | 0.00 | 411K | 18K | 75K | 16K | 0.00 | 0.00 | 0.00 | – | – | – |
| 銷售管理費用 | 2.1M | 1.8M | 10.6M | 2.0M | 1.5M | 1.5M | 1.8M | 1.4M | 1.4M | 13.0M | 2.6M | 2.0M |
| 營業利益 | −2.9M+11% | −2.2M+162% | −11.4M+409% | −1.8M-27% | −2.6M+44% | −833K-94% | −2.2M-26% | −2.5M-3% | −1.8M | −13.6M | −3.0M | −2.6M |
| 營業利益率 | -15.4% | -12.2% | -57.9% | -10.6% | -17.9% | -6.1% | -18.0% | -18.9% | -12.6% | -85.8% | -23.5% | -20.8% |
| 稅後淨利 | −6.1M+115% | −2.8M+243% | −10.1M+21% | −5.4M+107% | −2.8M+52% | −818K-94% | −8.4M+150% | −2.6M+164% | −1.9M | −13.8M | −3.3M | −982K |
| 淨利率 | -32.1% | -15.6% | -51.5% | -31.3% | -19.2% | -6.0% | -67.5% | -19.6% | -12.8% | -86.8% | -26.1% | -7.9% |
| 稀釋 EPS | -0.100% | -0.06+100% | -0.33-27% | -0.17+13% | -0.10-9% | -0.03-98% | -0.45+67% | -0.15+67% | -0.11 | -1.75 | -0.27 | -0.09 |
| 稀釋股數 | 59.9M | 47.1M | 30.3M | 30.6M | 28.8M | 26.0M | 18.4M | 17.8M | 16.9M | – | 12.6M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.8M | 515K | 716K | 889K | 656K | 743K | 3.3M | 344K | 865K | 3.8M | 2.4M | 2.2M |
| 應收帳款 | 18.9M | 18.2M | 19.6M | 18.0M | 15.5M | 14.3M | 17.5M | 18.4M | 19.1M | 19.8M | 25.6M | 23.6M |
| 存貨 | 4.5M | 5.7M | 5.8M | 5.7M | 5.1M | 4.7M | 4.9M | 4.3M | 4.9M | 4.8M | 6.0M | 4.8M |
| 總資產 | 61.5M | 62.4M | 65.5M | 69.5M | 61.8M | 57.2M | 64.5M | 60.8M | 62.3M | 66.0M | 71.5M | 68.6M |
| 有息負債 | 3.2M | 3.5M | 3.8M | 5.4M | 5.2M | 4.9M | 4.3M | 3.9M | 1.2M | 1.3M | 4.2M | 3.4M |
| 總負債 | 40.8M | 42.5M | 47.1M | 46.4M | 35.6M | 31.2M | 29.5M | 28.7M | 27.8M | 30.0M | 27.0M | 24.6M |
| 股東權益 | 20.7M | 19.8M | 18.4M | 23.1M | 26.2M | 26.0M | 35.0M | 32.1M | 34.5M | 36.0M | 44.2M | 43.7M |
| 負債比 | 66.4% | 68.2% | 71.9% | 66.7% | 57.6% | 54.6% | 45.8% | 47.2% | 44.6% | 45.4% | 37.7% | 35.8% |
| 淨現金(現金 − 有息負債) | −1.4M | −2.9M | −3.1M | −4.5M | −4.5M | −4.1M | −953K | −3.6M | −349K | 2.5M | −1.9M | −1.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.1M+473% | – | – | – | −186K | – | – | −3.4M | – | – | – |
| 資本支出 | – | 11K | – | – | – | 13K | – | – | 83K | – | – | – |
| 自由現金流 | – | −1.1M+442% | – | – | – | −199K | – | – | −3.5M | – | – | – |
| 折舊攤銷 | 349K | 347K | 313K | 378K | 354K | 316K | 304K | 313K | 312K | 167K | 249K | 127K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -6.0% | – | – | – | -1.5% | – | – | -24.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 65.3M
| Wholesale | 59.3M | 90.9% | +15.0% |
|---|---|---|---|
| Nutraceuticals And Pharmaceuticals | 4.3M | 6.5% | +116.7% |
| Pharmamanufacturing | 1.7M | 2.6% | +95.2% |
| 其他 | 1K | 0.0% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 65.3M | +19.9% | −19.1M | -29.3% | -0.63 | −8.5M |
| FY2024 | 54.4M | +2.0% | −16.2M | -29.7% | -1.17 | −8.1M |
| FY2023 | 53.4M | +6.0% | −18.5M | -34.7% | -2.15 | −16.9M |
| FY2022 | 50.3M | -10.5% | −13.8M | -27.5% | -33.16 | −14.9M |
| FY2021 | 56.2M | +1.5% | −8.0M | -14.2% | -23.74 | −7.7M |
| FY2020 | 55.4M | +39.6% | 821K | 1.5% | 0.06 | −11.6M |
| FY2019 | 39.7M | +7.0% | −3.3M | -8.3% | -0.25 | – |
| FY2018 | 37.1M | – | −9.1M | -24.4% | -0.68 | −2.1M |